Findings from a new study reveal significant racial differences in skin biopsy frequency for psoriasis diagnosis, indicating ...

The relationship between psoriasis and social anxiety highlights the intricate connection between physical and mental health.

Oruka Therapeutics (ORKA) has received a new Buy rating, initiated by Leerink Partners analyst, David Risinger. David Risinger has given his ...

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an ...

ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentationAdditionally, two posters on data from the pioneering use of tape stripping for biomarker ...

Vixarelimab is a monoclonal antibody commercialized by Roche, with a leading Phase II program in Plaque Psoriasis (Psoriasis Vulgaris).

Brepocitinib tosylate is a small molecule commercialized by Roivant Sciences, with a leading Phase III program in Dermatomyositis.

Italy: Psoriasis and psoriatic arthritis are associated with a higher risk of polyneuropathy, which appears to stem from a ...

Recent key milestones include the U.S. FDA approval of ZORYVE cream for treating plaque psoriasis and atopic dermatitis ... with the cost of sales at $3.5 million, R&D expenses at $19.3 million ...